Cellebrite DI's (NASDAQ:CLBT) stock up by 3.4% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually ...

Cellebrite remains a "Buy" as federal demand rebounds and platform adoption accelerates, supporting a strong long-term growth outlook. The federal segment returned to year-over-year growth in Q3, ...

Cellebrite delivered strong financial results in Q3 2025, exceeding analyst expectations with revenue of $126 million, an 18% increase year-over-year. Subscription revenue, a key focus area for the ...

Offers digital intelligence solutions, including data extraction, analytics, and investigative management platforms for law enforcement, government agencies, and enterprises. Serves federal, state, ...

Norwood initiated Cellebrite position and now holds 230,671 shares, worth an estimated $4.27 million. The stake represents 3.68% of 13F reportable assets under management. The trade makes Cellebrite ...

OpenAI opens ChatGPT to real apps. Developers can now submit MCP-powered tools for shopping, productivity, and more inside chat.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Understand the cash flow statement for Cellebrite DI Ltd. (CLBT), learn where the money comes from and how the company spends it.

Note The agentic-doc Python library is now legacy. Please migrate to the new landingai-ade library, which is now the official Python library for Agentic Document Extraction and supports our newer API ...